neoplasm
• fewer total intestinal adenoma at 20 weeks with prevented initiation of polyp formation compared with ApcMin heterozygotes
|
• reduced proliferation and increased apoptosis compared with tumors from ApcMin heterozygotes
|
homeostasis/metabolism
• 10-fold higher corticosterone (active glucocorticoid) levels in the intestine compared with ApcMin heterozygotes
• 11-keto-corticosterone (inactive glucocorticoid) levels is lower in the intestine compared with ApcMin heterozygotes
|
digestive/alimentary system
• fewer total intestinal adenoma at 20 weeks with prevented initiation of polyp formation compared with ApcMin heterozygotes
|